newborn_screen_follow-up_for_mucopolysaccharidosis_type_ii.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 02/2024 Newborn screening results: ■ Decreased iduronate-2-sulfatase activity ■ Elevated dermatan and heparan sulfate Order the following: ■ I2SWB /...
Urinary stone services - Insights
Learn how our approach to kidney stone services and concise reporting enable accurate interpretation to guide clinical decisions.
Emergency toxicology - Insights
Mayo Clinic Laboratories’ emergency toxicology testing can help providers manage overdose by clarifying whether symptoms are due to the presence of drugs.
specimen - Mayo Clinic Laboratories
COLLECTION AND PREPARATION Supplies Order specimen handling supplies....
newborn-screen-follow-up-elevated-c4-c5-acylcarnitine-elevated-acylcarnitines.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 09/2023 Newborn screen result: ■ Elevated C4 ■ Elevated C5 ■ Possible other acylcarnitine elevations Perform: Plasma ammonia, blood gas, glucose,...
New tests launched in December - Insights
December 2021, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Our renal diagnostics are backed by a multidisciplinary approach and an award-winning team of Mayo Clinic nephrology experts, pathologists, and laboratory scientists who work at the intersection of research and patient care.
New tests launched in March - Insights
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Check out Mayo Clinic Laboratories’ expert-developed biochemical and molecular testing to confirm a diagnosis of oligosaccharidosis.
Laboratory Identification Number: 29685A Name and Director of Laboratory: MAYO CLINIC LABS-ROCH SUPERIOR DR WILLIAM G. MORICE II 3050 SUPERIOR DRIVE NW ROCHESTER, MN 55901 Owner: MAYO CLINIC ISSUE DATE: August 15, 2024 DATE...